Literature DB >> 14381924

Use of dehydroisoandrosterone in psychiatric practice.

E B STRAUSS, W A STEVENSON.   

Abstract

Entities:  

Keywords:  ANDROGENS/therapeutic use; MENTAL DISORDERS/therapy

Mesh：

Substances：

Year:  1955        PMID： 14381924      PMCID： PMC503228          DOI： 10.1136/jnnp.18.2.137

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  4 in total

1.  Further studies on endocrine treatment in adolescence and early adult life.

Authors:  D E SANDS
Journal:  J Ment Sci       Date:  1954-01

2.  Regulation of urinary steroid excretion. 1. Effects of dehydroisoandrosterone and of anterior pituitary extract on the pattern of daily excretion in man.

Authors:  M Reiss; R E Hemphill; J J Gordon; E R Cook
Journal:  Biochem J       Date:  1949       Impact factor: 3.857

3.  Use of dehydroisoandrosterone in psychiatric treatment; a preliminary survey.

Authors:  E B STRAUSS; D E SANDS; A M ROBINSON; W J TINDALL; W A H STEVENSON
Journal:  Br Med J       Date:  1952-07-12

4.  Sex steroid therapy in psychiatric disorders; the therapeutic effect of testosterone and estradiol on hospitalized psychotics: clinical findings.

Authors:  M D SACKLER; R R SACKLER; A M SACKLER; F W CO TUI; J H W VAN OPHUIJSEN
Journal:  Acta Psychiatr Neurol Scand       Date:  1951
  4 in total
  2 in total

1.  A clinical trial of dehydroepiandrosterone (diandrone).

Authors:  A D FORREST; J DREWERY; K FOTHERBY; S G LAVERTY
Journal:  J Neurol Neurosurg Psychiatry       Date:  1960-02       Impact factor: 10.154

Review 2.  Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS).

Authors:  Nicole Maninger; Owen M Wolkowitz; Victor I Reus; Elissa S Epel; Synthia H Mellon
Journal:  Front Neuroendocrinol       Date:  2008-12-03       Impact factor: 8.606
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.